PROTEUS results reshape high‑risk localized prostate cancer care, adding apalutamide plus androgen deprivation before surgery as a new option.
Mary-Ellen Taplin, MD, FASCO
Advertisement
Articles by Mary-Ellen Taplin, MD, FASCO
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on AJMC
1
Emerging Data Suggest Survodutide Targets Liver Fat More Rapidly Than Weight Loss: Lee Kaplan, MD, PhD
2
Survodutide Normalizes Liver Fat in 61% of Patients With MASLD in Phase 3 Trial: Lee Kaplan, MD, PhD
3
Bridging Science and Reality in Diabetes Care
4
Survodutide Phase 3 Data Signal Metabolic Gains Beyond Weight Loss
5